1. Relative protein quantification and accessible biology in lung tumor proteomes from four LC‐MS/MS discovery platforms
   Paul A. Stewart et al, 2017, PROTEOMICS CrossRef
2. Ligand-independent integrin β1 signaling supports lung adenocarcinoma development
   Scott M. Haake et al, 2022, JCI Insight CrossRef
3. Cyclooxygenase-2 induced β1-integrin expression in NSCLC and promoted cell invasion via the EP1/MAPK/E2F-1/FoxC2 signal pathway
   Jinshun Pan et al, 2016, Scientific Reports CrossRef
4. Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma
   Chiung-Hung Hsu et al, 2016, Molecular & Cellular Proteomics CrossRef
5. lncRNA HITT inhibits metastasis by attenuating Rab5-mediated endocytosis in lung adenocarcinoma
   Xingwen Wang et al, 2022, Molecular Therapy CrossRef
6. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells
   XIAOMING BAI et al, 2014, Molecular Medicine Reports CrossRef
7. Functional polymorphisms of ITGB1 are associated with clinical outcome of Chinese patients with resected colorectal cancer
   Feng Zhou et al, 2015, Cancer Chemotherapy and Pharmacology CrossRef
8. VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop
   Asma Boudria et al, 2019, Oncogene CrossRef
9. Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma
   Kiyonaga Fujii et al, 2017, Expert Review of Proteomics CrossRef
10. Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study
    Shigeru Sakurai et al, 2024, Pathology and Oncology Research CrossRef